HomeNAV • CVE
add
Navco Pharmaceuticals Inc
Previous close
$0.0050
Year range
$0.0050 - $0.070
Market cap
285.35K CAD
Avg Volume
6.93K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.91K | -98.22% |
Net income | -18.11K | 95.43% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 8.64K | 102.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.24K | -10.48% |
Total assets | 19.24K | -98.14% |
Total liabilities | 904.54K | 7.80% |
Total equity | -885.30K | — |
Shares outstanding | 57.07M | — |
Price to book | -0.25 | — |
Return on assets | -45.76% | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -18.11K | 95.43% |
Cash from operations | -4.14K | 92.22% |
Cash from investing | — | — |
Cash from financing | 22.00K | 551.10% |
Net change in cash | 17.86K | 130.73% |
Free cash flow | 36.13K | -3.25% |
About
Headquarters
Website
